NCT04253145 - Study to Assess Safety,Tolerability,Efficacy of PM01183 and Atezolizumab in Patients w/ Advanced Small Cell Lung Cancer. | Biotech Hunter

Enrollment

184

Participants

Timeline

Start Date

December 13, 2019

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2025

Conditions

Carcinoma, Small Cell Lung

Interventions

DRUG

PM 01183

Lyophilisate for solution for infusion

DRUG

Atezolizumab

Concentrate for solution for infusion

Trial Locations (13)

RECRUITING

Hospital Virgen de la Victoria, Málaga

RECRUITING

Hospital Virgen del Rocio, Seville

RECRUITING

Hospital Universitario Marqués de Valdecilla, Santander

RECRUITING

Hospital Vall d'Hebron, Barcelona

RECRUITING

Hospital Universitario Da Coruña, A Coruña

RECRUITING

Hospital Clínic de Barcelona, Barcelona

RECRUITING

Hospital de la Santa Creu i Sant Pau, Barcelona

RECRUITING

Hospital 12 de Octubre, Madrid

RECRUITING

Hospital Universitario La Paz, Madrid

RECRUITING

Hospital Universitario Ramón y Cajal, Madrid

RECRUITING

Hospital Clínico Universitario Virgen de la Arrizaca, Murcia

RECRUITING

Hospital Universitario Virgen Macarena, Seville

RECRUITING

Hospital Clínico Universitario Lozano Blesa, Zaragoza